Deborah DeMuria

Debbie has over 25 years of experience leading global regulatory strategy efforts for a portfolio of products resulting in over 20 marketing approvals worldwide. She has been a key contributor to the development of drugs to treat oncology patients as well as those with rare diseases. Prior to joining Censa, Debbie served as a senior regulatory affairs professional with leading biopharmaceutical companies like EMD Serono, Coley Pharmaceuticals, Takeda Oncology and Merrimack Pharmaceuticals.  She has also served on NIH’s federal advisory board for NIAID Extramural research in developing products for biodefense, anti-microbial resistance and emerging infectious diseases. Debbie has a Doctor of Pharmacy degree from Massachusetts College of Pharmacy and completed a post-doctoral fellowship in clinical pharmacokinetics from the SUNY-Buffalo Clinical Pharmacokinetics Laboratory in Buffalo, New York.